Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,985 active trials259 approved drugs4,032 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05278975 | Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma | completed | Phase 1 / Phase 2 | 50 | RS Oncology LLCINDUSTRY | 1 | Jul 24, 2026 | clinicaltrials |
| NCT05570851 | Alcohol Cessation Among Head and Neck Cancer Survivors | completed | N/A | 126 | Northwell HealthOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors |
| completed |
| Phase 1 / Phase 2 |
| 8 |
| Seqker Biosciences, Inc.INDUSTRY |
| 1 |
| Jul 24, 2026 |
| clinicaltrials |
| NCT06663020 | Impact of Smoking Cessation Duration on Postoperative Complications in Lung Cancer Surgery | completed | — | 156 | Caner İşevi, MDOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT06838065 | Rehabilitation Management for Patients With Multiple Myeloma(FKTMM2022) | completed | — | 128 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07010224 | Elastofibroma Dorsi: Clinical Features, Surgical Outcomes, and Risk Factors | completed | — | 102 | Ondokuz Mayıs UniversityOTHER | 0 | Jul 24, 2026 | clinicaltrials |
| NCT07040631 | Hyaluronic Acid for Prevention of Post-Intubation Sore Throat and Hoarseness | completed | N/A | 132 | Pusan National University Yangsan HospitalOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07334626 | Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy(PilatesBCS2026) | completed | N/A | 60 | Benha UniversityOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07724314 | Effects of a Web-Based Alopecia Education Program in Women With Breast Cancer | completed | N/A | 68 | Gulay AkmanOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07725653 | Impact of Anterior Urethral Suspension Combined With Pelvic Fascia Reconstruction During Robot-Assisted Radical Prostatectomy on Early Postoperative Urinary Continence Recovery: A Single-Center, Prospective, Single-Arm Clinical Study(IAPREA) | completed | N/A | 60 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07725692 | Predictors of Rescue Surgery, Mortality, and Permanent Stoma After Anastomotic Leak Following Colorectal Cancer Resection(leak predictor) | completed | — | 3,200 | Alexandria UniversityOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT02821559 | Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer(EROS) | completed | Phase 2 | 37 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT02905578 | A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) | completed | Phase 2 | 40 | University of IowaOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT03117946 | Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy(i-RTCT) | completed | N/A | 136 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT03374332 | Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia | completed | Phase 1 / Phase 2 | 11 | Brown UniversityOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT03410030 | Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)(AA NABPLAGEM) | completed | Phase 1 / Phase 2 | 17 | HonorHealth Research InstituteOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT03586661 | Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 1 | 31 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT03712878 | 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies | completed | Phase 2 | 10 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT03836209 | Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia | completed | Phase 2 | 181 | PrECOG, LLC.OTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT04158440 | Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC | completed | Phase 3 | 501 | Shanghai Junshi Bioscience Co., Ltd.OTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT04553926 | 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)(OLAP) | completed | — | 661 | AstraZenecaINDUSTRY | 1 | Jul 23, 2026 | clinicaltrials |
| NCT05005715 | Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery | completed | Phase 2 | 64 | Seoul National University HospitalOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT05034627 | Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 1 | 15 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT06589154 | The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis | completed | — | 1,651 | Shanghai Changzheng HospitalOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07723365 | Epidemiological, Clinicopathological, and Surgical Characteristics of Eyelid Carcinomas(epidemiology) | completed | — | 20 | Mohammed VI University HospitalOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT00076310 | OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer | completed | Phase 2 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT03729518 | TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck | completed | N/A | 150 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT03796767 | Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer(SOAR) | completed | Phase 2 | 20 | University of UtahOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT03924856 | Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)(KEYNOTE-866) | completed | Phase 3 | 907 | Merck Sharp & Dohme LLCINDUSTRY | 22 | Jul 22, 2026 | clinicaltrials |
| NCT04081246 | Transurethral Modified En Bloc Resection For Large Bladder Tumours. | completed | N/A | 30 | Chinese University of Hong KongOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT04210115 | Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) | completed | Phase 3 | 703 | Merck Sharp & Dohme LLCINDUSTRY | 27 | Jul 22, 2026 | clinicaltrials |
| NCT04776447 | Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)(APOLO) | completed | Phase 2 | 38 | Fundación GECPOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT04864418 | AST-021p Study in Advanced Solid Tumors | completed | Phase 1 | 22 | Aston Sci. Inc.INDUSTRY | 1 | Jul 22, 2026 | clinicaltrials |
| NCT04892810 | Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma(PAI²HCC) | completed | — | 20 | University Hospital, GrenobleOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT05198934 | Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation(CodeBreak300) | completed | Phase 3 | 160 | AmgenINDUSTRY | 12 | Jul 22, 2026 | clinicaltrials |
| NCT05832008 | Increasing Adherence to Lung Cancer Screening | completed | N/A | 825 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT06666634 | Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy(NANOSCAN) | completed | N/A | 29 | The Netherlands Cancer InstituteOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT07718919 | Multicentric National Italian Analysis of Textbook Outcome in Colorectal Cancer Surgery(ATOCCS) | completed | — | 6,129 | Academy of Applied Medical and Social Sciences, PolandOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT07720011 | Interim PET/CT-adapted Use of PD-1 Inhibitor Combined With De-escalated Chemotherapy-AVD in Classic Hodgkin Lymphoma | completed | Phase 2 | 130 | Peking University People's HospitalOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT07721194 | Primary Bone Mature B-Cell NHL in Children | completed | — | 21 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT01708941 | Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery | completed | Phase 2 | 88 | National Cancer Institute (NCI)NIH | 1 | Jul 21, 2026 | clinicaltrials |
| NCT02337829 | Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL | completed | Phase 2 | 48 | Acerta Pharma BVINDUSTRY | 1 | Jul 21, 2026 | clinicaltrials |
| NCT02389244 | A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas(REGOBONE) | completed | Phase 2 | 163 | UNICANCEROTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT03006848 | A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma | completed | Phase 2 | 19 | St. Jude Children's Research HospitalOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT03048942 | Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer(CONCEPT) | completed | Phase 2 | 158 | University Hospitals Bristol and Weston NHS Foundation TrustOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT03677427 | Comparing 5 and 15 Fractions for Whole Breast Irradiation After Breast Conserving Surgery(YO-HAI5) | completed | N/A | 488 | University Hospital, GhentOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT03958747 | Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy | completed | N/A | 20 | Wake Forest University Health SciencesOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT04537286 | First-line Nab-paclitaxel Plus Cisplatin Plus Camrelizumab in mTNBC Patients | completed | Phase 2 | 90 | Fudan UniversityOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT04620915 | Construal Level as a Novel Pathway for Affect Regulation and Cancer Control | completed | N/A | 300 | University of OregonOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT04669197 | Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer | completed | Phase 2 | 19 | HonorHealth Research InstituteOTHER | 1 | Jul 21, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Jul 24, 2026source: clinicaltrials